Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Bichmann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Neuro-Oncology Advances|May 16, 2025
The immunopeptidomic landscape of ependymomas provides actionable antigens for T-cell-based immunotherapyLena Mühlenbruch, David Rieger, Hannes Becker, et al.
Iscience|February 10, 2022
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissuesPeter Kubiniok, Ana Marcu, Leon Bichmann, et al.
Journal of Neuroinflammation|April 14, 2026
Extensive peripheral immunoglobulin repertoire analyses in people with multiple sclerosis reveal disease-specific signatures and distinct treatment effects of disease modifying drugsNicole Vasilenko, Christoph Ruschil, Josua Stadelmaier, et al.
The Journal of Experimental Medicine|December 24, 2019
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion modelsMaren Lübke, Stefanie Spalt, Daniel J Kowalewski, et al.
Journal for Immunotherapy of Cancer|August 31, 2025
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometryLeon Bichmann, Ana Marcu, Daniel Johannes Kowalewski, et al.
British Journal of Cancer|February 24, 2023
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccinationLena Mühlenbruch, Tsima Abou-Kors, Marissa L Dubbelaar, et al.
Blood|December 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyTatjana Bilich, Annika Nelde, Leon Bichmann, et al.
Journal for Immunotherapy of Cancer|April 16, 2021
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapyAna Marcu, Leon Bichmann, Leon Kuchenbecker, et al.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Nature Methods|February 17, 2024
OpenMS 3 enables reproducible analysis of large-scale mass spectrometry dataJulianus Pfeuffer, Chris Bielow, Samuel Wein, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuro-Oncology Advances|May 16, 2025
The immunopeptidomic landscape of ependymomas provides actionable antigens for T-cell-based immunotherapyLena Mühlenbruch, David Rieger, Hannes Becker, et al.
Iscience|February 10, 2022
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissuesPeter Kubiniok, Ana Marcu, Leon Bichmann, et al.
Journal of Neuroinflammation|April 14, 2026
Extensive peripheral immunoglobulin repertoire analyses in people with multiple sclerosis reveal disease-specific signatures and distinct treatment effects of disease modifying drugsNicole Vasilenko, Christoph Ruschil, Josua Stadelmaier, et al.
The Journal of Experimental Medicine|December 24, 2019
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion modelsMaren Lübke, Stefanie Spalt, Daniel J Kowalewski, et al.
Journal for Immunotherapy of Cancer|August 31, 2025
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometryLeon Bichmann, Ana Marcu, Daniel Johannes Kowalewski, et al.
British Journal of Cancer|February 24, 2023
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccinationLena Mühlenbruch, Tsima Abou-Kors, Marissa L Dubbelaar, et al.
Blood|December 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyTatjana Bilich, Annika Nelde, Leon Bichmann, et al.
Journal for Immunotherapy of Cancer|April 16, 2021
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapyAna Marcu, Leon Bichmann, Leon Kuchenbecker, et al.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Nature Methods|February 17, 2024
OpenMS 3 enables reproducible analysis of large-scale mass spectrometry dataJulianus Pfeuffer, Chris Bielow, Samuel Wein, et al.
Pageof 2